Plus-size retailer joins forces with breast cancer charity

By Alex Brodie
Plus-size retailer Lane Bryant is joining forces with its customers to fight breast cancer together by donating a percentage of sales income to charity...

Plus-size retailer Lane Bryant is joining forces with its customers to fight breast cancer together by donating a percentage of sales income to charity.

A special 50-piece collection - Cacique + LIVI Active - dedicated to the Breast Cancer Research Foundation (BCRF) will be on offer to customers and 10% of the purchase price of items bought in October will be donated to the foundation.

Should Lane Bryant customers want to further contribute to BCRF through the end of October, they can also buy a coupon book with a $5 donation.

The link-up will benefit a special research initiative funded through BCRF, a project studying the effect of novel chemotherapy drugs in Triple Negative breast cancer (TNBC) cells, which tend to exhibit aggressive behaviour and are more likely to spread to another part of the body, becoming incurable.

The promotion comes after the recent discovery that TNBCs could be sensitive to new drugs called CDK4/6 inhibitors.

Researchers at The Institute of Cancer Research, London, demonstrated in cell-lines and in mice that palbociclib could be used effectively to treat certain triple negative breast cancers. Trials will now be carried out in patients.

Breast cancer is the second leading cause of cancer death in women

BCRF in 2017 will give $59.5m to support the work of more than 275 scientists at leading medical and academic institutions across 15 countries, making BCRF the largest private funder of breast cancer research worldwide.

The American Cancer Society estimates about 252,710 new cases of invasive breast cancer will be diagnosed in US women in 2017 and about 40,610 women will die from breast cancer.

It is the second leading cause of cancer death in women. Only lung cancer kills more women each year. The chance that a woman will die from breast cancer is about 1 in 37.

For more information, go to Breast Cancer Research FoundationAmerican Cancer Society, Lane Bryant

Share

Featured Articles

Comarch Diagnostic Point Boost for European Health Insurance

Healthtech specialist Comarch introduces Diagnostic Point, designed to improve health insurance across European markets

McKinsey: Women More Likely to die of Heart Attack Than Men

McKinsey Health Institute's Lucy Pérez says cardiovascular disease top killer of women yet physicians don't know their heart attack symptoms are different

Novo Nordisk Buys $1bn Cardior in CardioVascular Move

As Novo Nordisk expands into heart medicines, we profile the Danish pharma giant who in 1923 was the first to make insulin commercially available

Shoddy Chinese Syringes Sees BD Ramp-up Production

Procurement & Supply Chain

AI Tool 'Picks up Early-stage Breast Cancers Doctors Missed'

Technology & AI

AstraZeneca Buys $2bn Fusion in Next-gen Cancer Drugs Move

Medical Devices & Pharma